{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:57:22Z","timestamp":1773795442358,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2012,10,5]],"date-time":"2012-10-05T00:00:00Z","timestamp":1349395200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1038\/eye.2012.195","type":"journal-article","created":{"date-parts":[[2012,10,8]],"date-time":"2012-10-08T10:31:48Z","timestamp":1349692308000},"page":"1465-1472","source":"Crossref","is-referenced-by-count":60,"title":["Adverse periocular reactions to five types of prostaglandin analogs"],"prefix":"10.1038","volume":"26","author":[{"given":"K","family":"Inoue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Shiokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Higa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Sugahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Soga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Wakakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,10,5]]},"reference":[{"key":"BFeye2012195_CR1","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.ophtha.2009.01.036","volume":"116","author":"JW Cheng","year":"2009","unstructured":"Cheng JW, Cai JP, Wei RL . Meta-analysis of medical intervention for normal tension glaucoma. Ophthalmology 2009; 116: 1243\u20131249.","journal-title":"Ophthalmology"},{"key":"BFeye2012195_CR2","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1177\/112067210601600209","volume":"16","author":"U Elgin","year":"2006","unstructured":"Elgin U, Batman A, Berker N, Ilhan B . The comparison of eyelashes lengthening effect of latanoprost therapy in adults and children. Eur J Ophthalmol 2006; 16: 247\u2013250.","journal-title":"Eur J Ophthalmol"},{"key":"BFeye2012195_CR3","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1080\/02713680701750625","volume":"32","author":"ED Sharpe","year":"2007","unstructured":"Sharpe ED, Reynolds AC, Skuta GL, Jenkins JN, Stewart WC . The clinical impact and incidence of periocular pigmentation associated with either latanoprost or bimatoprost therapy. Cur Eye Res 2007; 32: 1037\u20131043.","journal-title":"Cur Eye Res"},{"key":"BFeye2012195_CR4","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/S0002-9394(03)00098-9","volume":"135","author":"RK Parrish","year":"2003","unstructured":"Parrish RK, Palmberg P, Sheu W-P . A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study. Am J Ophthalmol 2003; 135: 688\u2013703.","journal-title":"Am J Ophthalmol"},{"key":"BFeye2012195_CR5","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1097\/00061198-200204000-00003","volume":"11","author":"A Kampik","year":"2002","unstructured":"Kampik A, Arias-Puente A, O\u2019Brart DPS, Vuori M . The European latanoprost study group. Intraocular pressure-lowering effects of latanoprost and brimonidine therapy in patients with open-angle glaucoma or ocular hypertension: a randomized observer-masked multicenter study. J Glaucoma 2002; 11: 90\u201396.","journal-title":"J Glaucoma"},{"key":"BFeye2012195_CR6","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1097\/IJG.0b013e3181c4aeac","volume":"19","author":"CM Birt","year":"2010","unstructured":"Birt CM, Buys YM, Ahmed IIK, Trope GE . The Toronto area glaucoma society. Prostaglandin efficacy and safety study undertaken by race (the pressure study). J Glaucoma 2010; 19: 460\u2013467.","journal-title":"J Glaucoma"},{"key":"BFeye2012195_CR7","first-page":"581","volume":"110","author":"K Inoue","year":"2006","unstructured":"Inoue K, Wakakura M, Inoue J, Matsuo H, Hara T, Tomita G . Adverse reactions after use of latanoprost in Japanese glaucoma patients. Nippon Ganka Gakkai Zasshi (in Japanese) 2006; 110: 581\u2013587.","journal-title":"Nippon Ganka Gakkai Zasshi (in Japanese)"},{"key":"BFeye2012195_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2147\/OPTH.S27489","volume":"6","author":"K Inoue","year":"2012","unstructured":"Inoue K, Shiokawa M, Sugahara M, Higa R, Wakakura M, Tomita G . Iris and periocular adverse reactions to bimatoprost in Japanese patients with glaucoma or ocular hypertension. Clin Ophthalmol 2012; 6: 111\u2013116.","journal-title":"Clin Ophthalmol"},{"key":"BFeye2012195_CR9","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00417-004-0866-2","volume":"242","author":"G Manni","year":"2004","unstructured":"Manni G, Centofanti M, Parravano M, Oddone F, Bucci MG . A 6-month randomized clinical trial of bimatoprost 0.03% versus the association of timolol 0.5% and latanoprost 0.005% in glaucomatous patients. Grafe\u2019s Arch Clin Exp Ophthalmol 2004; 242: 767\u2013770.","journal-title":"Grafe\u2019s Arch Clin Exp Ophthalmol"},{"key":"BFeye2012195_CR10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s10384-003-0039-6","volume":"48","author":"T Chiba","year":"2004","unstructured":"Chiba T, Kashiwagi K, Ishijima K, Furuichi M, Kogure S, Abe K et al. A prospective study of iridial pigmentation and eyelash changed due to ophthalmic treatment with latanoprost. Jpn J Ophthalmol 2004; 48: 141\u2013147.","journal-title":"Jpn J Ophthalmol"},{"key":"BFeye2012195_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0002-9394(02)01827-5","volume":"135","author":"RS Noecker","year":"2003","unstructured":"Noecker RS, Dirks MS, Choplin NT, Bernstein P, Batoosingh AL, Whitecup SM et al. A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma. Am J Ophthalmol 2003; 135: 55\u201363.","journal-title":"Am J Ophthalmol"},{"key":"BFeye2012195_CR12","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/BF02850299","volume":"18","author":"S Gandolfi","year":"2001","unstructured":"Gandolfi S, Simmons ST, Sturm R, Chen K, VanDenburgh AM . Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension. Ad Ther 2001; 18: 110\u2013121.","journal-title":"Ad Ther"},{"key":"BFeye2012195_CR13","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/S0002-9394(01)01177-1","volume":"132","author":"PA Netland","year":"2001","unstructured":"Netland PA, Landry T, Sullivan EK, Andrew R, Silver L, Weiner A et al. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension. Am J Ophthalmol 2001; 132: 472\u2013484.","journal-title":"Am J Ophthalmol"},{"key":"BFeye2012195_CR14","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1067\/mjd.2001.111625","volume":"44","author":"T Demitsu","year":"2001","unstructured":"Demitsu T, Manbe M, Harima N, Sugiyama T, Yoneda K, Yamada N . Hypertrichosis induced by latanoprost. J Am Acad Dermatol 2001; 44: 721\u2013723.","journal-title":"J Am Acad Dermatol"},{"key":"BFeye2012195_CR15","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0161-6420(01)00584-X","volume":"108","author":"JD Brandt","year":"2001","unstructured":"Brandt JD, VanDenburgh AM, Chen K, Whitcup SM . Comparison of once-or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP. Ophthalmology 2001; 108: 1023\u20131032.","journal-title":"Ophthalmology"},{"issue":"Suppl. 1","key":"BFeye2012195_CR16","doi-asserted-by":"publisher","first-page":"S203","DOI":"10.1016\/S0039-6257(02)00294-1","volume":"47","author":"K Miyake","year":"2002","unstructured":"Miyake K, Ibaraki N . Prostaglandins and cystoid macular edema. Surv Ophthalmol 2002; 47 (Suppl. 1): S203\u2013S218.","journal-title":"Surv Ophthalmol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/eye2012195.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye2012195","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye2012195.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:17:04Z","timestamp":1684430224000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/eye2012195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,5]]},"references-count":16,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["BFeye2012195"],"URL":"https:\/\/doi.org\/10.1038\/eye.2012.195","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,5]]}}}